WebJun 6, 2024 · Improvement in profitability and outperformance against the industry can be important characteristics in a stock for some investors. Below, I will assess Celsion Corporation’s (NASDAQ:CLSN) track record on a highRead More... WebMar 20, 2024 · Imunon (NASDAQ:CLSN) has a recorded net income of -$20.77 million. CLSN has generated $0.00 earnings per share over the last four quarters.
CLSN Price Target 2024 Imunon Analyst Ratings
WebJan 22, 2024 · add_box. LAWRENCEVILLE, NJ, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements ... WebFeb 25, 2024 · Celsion Corporation's (NASDAQ:CLSN): Celsion Corporation, a development stage oncology drug company, focuses on the... fzlbb
CLSN Stock Forecast, Price & News (Celsion) - MarketBeat
WebCLSN - Celsion Corporation, stock quotes, stock charts, news, financials, short interest, message boards, insiders, holders, calendars, competitors, historical quotes, option … WebSep 3, 2024 · by Zacks Equity Research Published on September 03,2024. Celsion (CLSN) announces data from pre-clinical studies for its investigational vaccine platform as a potential treatment for COVID-19. PFE ... WebNov 6, 2024 · NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Celsion Corporation (NASDAQ:CLSN) between November 2, 2015 and July 10, 2024, inclusive (the "Class Period"). fzlblw